ReviewInternational journal of molecular sciences2026
Potential Antidote Against Lead Toxicity-A Review.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As chronic lead (Pb) exposure is a serious threat to public health in many countries, we intended to provide a review of the effective antidote for Pb intoxication. In this context, we explored the recent literature focusing on animal studies that provide clear evidence of the efficacy of supplementation with certain antioxidants, such as spirulina, curcumin, garlic, vitamin C, and vitamin E, for different periods of time, in the conditions of Pb exposure, drawing attention to the mechanisms of their beneficial action. Data collected clearly indicate that spirulina, curcumin, garlic, vitamin C, and vitamin E may play an important role in alleviating some of the toxic effects caused by Pb. Their use may represent an interesting direction in the development of new therapies to combat the toxicity of this toxic, non-essential metal. However, it seems essential to identify a safe dose range for these antioxidants in order to derive benefits from their properties during Pb intoxication. Clinical trials seem to be necessary to recognize the long-term effects of supplementation with these antioxidants and to establish the minimum effective dose with minimal side effects. Future studies are also required to elucidate the molecular mechanisms of action of spirulina, curcumin, garlic, vitamin C, and vitamin E against Pb toxicity and the mechanisms of their interactions with chelating agents to enhance potential beneficial effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.